|
DELIVERING BIOTECH TOOLS TO LIFE
SCIENTISTS
Cartagen Molecular Takes Its Place
on Seattle’s First Hill
SEATTLE, WA- August 15th, 2003- Cartagen
Molecular Systems Inc., a new resource
for innovative reagent products for use
in the life science research markets,
has established its headquarters here
in Seattle. Joining their peers, and potential
customers, Cartagen has moved into the
historic Eklind Hall at the Seattle Life
Science Center in the heart of First Hill’s
‘Biotech Corridor’.
Founding President and CEO Steven Kirsher
has built a strong team of hand picked
scientists focused on producing high value
products at competitive prices. The Director
of Operations for the Seattle facility
is research scientist and long time Puget
Sound resident Samuel Chu. Prior to founding
Cartagen, Kirsher held key positions in
both domestic and international sales,
marketing and manufacturing operations
with companies such as Applied Biosystems,
Arcturus and Life Technologies.
“We partner with other small to
mid-sized biotech companies to enable
our customer’s early access to leading
edge technology.” Kirsher explains,
“With experience in research, production
and distribution, we can deliver highly
useful and effective tools at a reasonable
price, without making them navigate through
a large corporation.”
Indicative of this approach is Cartagen’s
launch of their new Total RNA Isolation
Kit. One of several products being introduced
this fall, The Total RNA Isolation Kit,
can be used to isolate high quality total
RNA from almost any source material, including
animal and plant tissue, blood, cultured
cells, bacteria, and yeast.
Kirsher adds that Cartagen Molecular Systems
also provides contract and OEM manufacturing
services for companies seeking to outsource
development and production. “We
offer production skills with strong attention
to quality and economy, and we recognize
the strength of Seattle’s research
community. Puget Sound’s strong
biotech roots, work ethic and quality
of life made it an obvious location to
establish our US manufacturing operations.
We see enormous potential for growth here.”
|
